Furthermore, in a comprehensive TMA of human breast cancers, high expression of RUNX2 was correlated with ER-negative disease and poor prognosis of patients as well as inducing preneoplastic changes in naïve murine mammary epithelial tissue [135]. This evidence concerns the gene RUNX2 and breast cancer.